Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

Isavuconazole (ISA) is a triazole antifungal agent recommended for treatment of invasive aspergillosis or mucormycosis. The objective of this study was to evaluate ISA levels in a real world setting in a mixed patient cohort including patients with non-malignant diseases and extracorporeal treatment...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Christoph Zurl, Maximilian Waller, Franz Schwameis, Tina Muhr, Norbert Bauer, Ines Zollner-Schwetz, Thomas Valentin, Andreas Meinitzer, Elisabeth Ullrich, Stefanie Wunsch, Martin Hoenigl, Yvonne Grinschgl, Juergen Prattes, Abderrahim Oulhaj, Robert Krause
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2020-06-01
Serie:	Journal of Fungi
Soggetti:	isavuconazole fungal infections therapeutic drug monitoring anti-infective agents antifungal therapy
Accesso online:	https://www.mdpi.com/2309-608X/6/2/90
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!